Chad Harris is an accomplished Business Development Manager at MilliporeSigma, where he leverages over 20 years of experience in the pharmaceutical and biotechnology sectors to drive growth and innovation in the Mid-Atlantic and Southeastern regions of the United States. His current role focuses on the...
Chad Harris is an accomplished Business Development Manager at MilliporeSigma, where he leverages over 20 years of experience in the pharmaceutical and biotechnology sectors to drive growth and innovation in the Mid-Atlantic and Southeastern regions of the United States. His current role focuses on the strategic expansion of MilliporeSigma’s Contract Development and Manufacturing Organization (CDMO) services, particularly in the rapidly evolving field of mRNA manufacturing. Chad's expertise encompasses a fully integrated offering that includes lipid supply, lipid nanoparticle (LNP) formulation and filling, as well as early-stage LNP formulation development.
In his capacity, Chad is instrumental in identifying and nurturing collaboration opportunities with new clients while simultaneously managing and enhancing relationships with existing partners. His approach is characterized by a commitment to operational excellence and continuous improvement, ensuring that client needs are met with the highest standards of quality and efficiency. Utilizing his skills in project management and cross-functional team leadership, Chad effectively coordinates resources and aligns stakeholders to achieve successful outcomes in new product launches and process improvements.
Chad’s proficiency in Lean Six Sigma methodologies further enables him to implement innovative solutions that streamline operations and enhance productivity. His collaborative problem-solving skills are essential in navigating the complexities of the biotech landscape, allowing him to address challenges head-on and deliver tailored solutions that drive client success. As a leader in business development, Chad Harris is dedicated to advancing the capabilities of MilliporeSigma’s CDMO services, positioning the company as a trusted partner in the pharmaceutical and biotech industries.
